223.1 Outcomes after emergent ABO-incompatible living donor liver transplantation
Mr. Sunghyo An, Korea
223.2 Outcomes of redo-liver transplantation using hypothermic oxygenated machine perfusion: a multicentre cohort study (REDO-HOPE)
Dr. Damiano Patrono, Italy
223.3 Successful Implementation of Pure Laparoscopic Right Donor Hepatectomy in a Small Center with Limited Experience: The Role of Proctorship Program
Dr. Manuel Lim, Korea
223.4 The outcomes of simultaneous liver–kidney transplantations with a positive crossmatch during safety net policy era in the United States
Ryosuke Misawa, United States
223.5 Biodegradable stent for biliary reconstruction in pediatric liver transplantation, surgical approach
Dr. Monserrat Arreola Gutiérrez, Mexico
223.6 Laparoscopic living donor hepatectomy for s2 graft using fluorescence imaging
Dr. Vyacheslav R Salimov, Russian Federation
223.7 Liver resection versus transplantation for management of combined hepatocellular-cholangiocarcinoma (cHCC-CCA)
Dr. Utpala Uday, India
223.8 Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
Sukmin Kwon, Korea
223.9 Experience with living donor liver transplantation for unresectable perihilar cholangiocarcinoma
Dr. Takashi Ito, Japan
223.10 Recurrence of hepatocellular carcinoma after liver transplantation: A single-center experience
Aydan Farzaliyeva, Turkey
223.11 The impact of loco-regional therapy on long term outcomes of liver transplant recipients for hepatocellular carcinoma